Lupin bags USFDA approval for Fesoterodine Fumarate ER Tablets Ruchika Sharma10 Jan 2023 3:22 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
COVID surge: Indian generic medicines demand hike in China Ruchika Sharma9 Jan 2023 3:32 PM IST"On the Chinese e-commerce platforms... At least four generic COVID drugs produced in India - Primovir, Paxista, Molnunat, and Molnatris - have been...
Pfizer 20-Valent Pneumococcal Conjugate Vaccine for infants, children accepted by USFDA for Priority Review Ruchika Sharma8 Jan 2023 4:15 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental Biologics...
Pfizer, Longevity Biotech Gero join hands to discover potential targets for fibrotic diseases Ruchika Sharma8 Jan 2023 11:00 AM ISTUS: Gero has announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to...
Pfizer to scale down early-stage rare disease research Ruchika Sharma6 Jan 2023 3:30 PM ISTPfizer said its oncology research portfolio will become even more focused around breast, prostate and hematological cancer franchises.
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Alembic Pharma bags USFDA nod for Fesoterodine Fumarate ER Tablets to treat overactive bladder Ruchika Sharma6 Jan 2023 12:30 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Pfizer India announces 12-week paternity leave policy for its workforce Ruchika Sharma5 Jan 2023 3:29 PM ISTThe paternity leave policy offers birthing and non-birthing fathers the flexibility to avail leaves over a period of two years.
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
Pfizer Pentavalent Meningococcal Vaccine under USFDA review Ruchika Sharma31 Dec 2022 10:00 AM ISTPfizer’s MenABCWY vaccine candidate combines the components of two vaccines into one, helping protect against the meningococcal serogroups that cause...
FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid Ruchika Sharma26 Dec 2022 4:15 PM ISTThe combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).
CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib Dr. Divya Colin25 Dec 2022 4:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
